Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 73694

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
October 20, 2014
Product types
Device
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Diamedix Corporation

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 3

Diamedix Is-Mumps IgG Test Kit Diamedix Is-Mumps IgG Test Kit is an EIA procedure intended for the qualitative and semi-quantitative detection of Mumps IgG antibodies as an aid in the diagnosis of Mumps infection.

Z-1685-2016
Recall number
Z-1685-2016
Initiated
October 20, 2014
Classification
Class II
Status
Terminated
Recalling firm
Diamedix Corporation
Quantity
697 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
A gel-like substance was found in kit component, sample diluent , that could potentially compromise product performance.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

A gel-like substance was found in kit component, sample diluent , that could potentially compromise product performance.

Code information

Lot # 20804, Catalog # 720-540. Expiration Date August 31, 2015

Distribution pattern

Worldwide distribution: US nationwide including states of: AZ, CA, CO, FL, GA, IL, IN, KY, MA, MI, MO, NC, NE, NH, NJ, NY, OH, OK, OR, PA, RI, TN, TX, VA, WI and Puerto Rico. and Country of: ITALY.

device · product 2 of 3

Diamedix Is-EBV-VCA IgG Test Kit Diamedix Is-Mumps IgG Test Kit is an EIA procedure intended for the qualitative and semi-quantitative detection of Mumps IgG antibodies as an aid in the diagnosis of Mumps infection.

Z-1686-2016
Recall number
Z-1686-2016
Initiated
October 20, 2014
Classification
Class II
Status
Terminated
Recalling firm
Diamedix Corporation
Quantity
588 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
A gel-like substance was found in kit component, sample diluent , that could potentially compromise product performance.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

A gel-like substance was found in kit component, sample diluent , that could potentially compromise product performance.

Code information

Lot # 30804, Catalog # 720-600 Expiration Date April 30, 2015

Distribution pattern

Worldwide distribution: US nationwide including states of: AZ, CA, CO, FL, GA, IL, IN, KY, MA, MI, MO, NC, NE, NH, NJ, NY, OH, OK, OR, PA, RI, TN, TX, VA, WI and Puerto Rico. and Country of: ITALY.

device · product 3 of 3

Diamedix Is-EBV-EA-D IgG Test Kit Diamedix Is-Mumps IgG Test Kit is an EIA procedure intended for the qualitative and semi-quantitative detection of Mumps IgG antibodies as an aid in the diagnosis of Mumps infection.

Z-1687-2016
Recall number
Z-1687-2016
Initiated
October 20, 2014
Classification
Class II
Status
Terminated
Recalling firm
Diamedix Corporation
Quantity
94 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
A gel-like substance was found in kit component, sample diluent , that could potentially compromise product performance.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

A gel-like substance was found in kit component, sample diluent , that could potentially compromise product performance.

Code information

Lot # 51104, Catalog # 720-640 Expiration Date August 31, 2015

Distribution pattern

Worldwide distribution: US nationwide including states of: AZ, CA, CO, FL, GA, IL, IN, KY, MA, MI, MO, NC, NE, NH, NJ, NY, OH, OK, OR, PA, RI, TN, TX, VA, WI and Puerto Rico. and Country of: ITALY.